GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai Municipality

Tenth People's Hospital of Tongji University, Shanghai, Shanghai Municipality